Epigenomics AG – OTC:EPGNY

Epigenomics AG stock price today

$2.39
Financial Health
0
1
2
3
4
5
6
7
8
9

Epigenomics AG key metrics

Market Cap
 1.95M
Enterprise value
 16.46M
P/E
 -1.60
EV/Sales
 29.04
EV/EBITDA
 -2.52
Price/Sales
 46.88
Price/Book
 1.90
PEG ratio
 -0.01
EPS
 -0.43
Revenue
 567K
EBITDA
 -6.51M
Income
 -7.30M
Revenue Q/Q
 -97.49%
Revenue Y/Y
 -91.03%
Profit margin
 -1279.54%
Oper. margin
 -1270.55%
Gross margin
 75.84%
EBIT margin
 -1270.55%
EBITDA margin
 -1148.68%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Epigenomics AG stock price history

Epigenomics AG stock forecast

Epigenomics AG financial statements

Profit Margin

Epigenomics AG (OTC:EPGNY): Profit margin
Dec 2021 181K -1.73M -959.67%
Mar 2022 115K -2.65M -2310.43%
Jun 2022 126K -1.32M -1053.17%
Sep 2022 145K -1.58M -1092.41%
EPGNY income statement history

Debt to Assets

Epigenomics AG (OTC:EPGNY): Debt to assets
Dec 2021 24663000 2.54M 10.31%
Mar 2022 22438000 3.35M 14.93%
Jun 2022 20620000 3.95M 19.18%
Sep 2022 18970000 5.03M 26.55%
EPGNY balance sheet history

Cash Flow

Epigenomics AG (OTC:EPGNY): Cash Flow
Dec 2021 -553K -24K -499K
Mar 2022 -3.27M -134K -96K
Jun 2022 -2.67M -203K -112K
Sep 2022 -2.48M -152K -220K
EPGNY cash flow history

Epigenomics AG alternative data

Epigenomics AG
Employees

Epigenomics AG (OTC:EPGNY): Employee count
Aug 2023 33
Sep 2023 33
Oct 2023 33
Nov 2023 33
Dec 2023 33
Jan 2024 33
Feb 2024 33
Mar 2024 33
Apr 2024 33
May 2024 33
Jun 2024 33
Jul 2024 33

Epigenomics AG other data

Frequently Asked Questions (FAQ)

  • What's the price of Epigenomics AG stock today?

    One share of Epigenomics AG stock can currently be purchased for approximately $2.39.

  • When is Epigenomics AG's next earnings date?

    Unfortunately, Epigenomics AG's (EPGNY) next earnings date is currently unknown.

  • Does Epigenomics AG pay dividends?

    No, Epigenomics AG does not pay dividends.

  • How much money does Epigenomics AG make?

    Epigenomics AG has a market capitalization of 1.95M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 636.7% to 6.2M US dollars.

  • What is Epigenomics AG's stock symbol?

    Epigenomics AG is traded on the OTC under the ticker symbol "EPGNY".

  • What is Epigenomics AG's primary industry?

    Company operates in the Healthcare sector and Diagnostics & Research industry.

  • How do i buy shares of Epigenomics AG?

    Shares of Epigenomics AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Epigenomics AG have?

    As Jul 2024, Epigenomics AG employs 33 workers.

  • When Epigenomics AG went public?

    Epigenomics AG is publicly traded company for more then 12 years since IPO on 10 Jul 2013.

  • What is Epigenomics AG's official website?

    The official website for Epigenomics AG is epigenomics.com.

  • How can i contact Epigenomics AG?

    Epigenomics AG can be reached via phone at +49 30 243450.

Epigenomics AG company profile:

Epigenomics AG

epigenomics.com
Exchange:

OTC

Full time employees:

33

Industry:

Diagnostics & Research

Sector:

Healthcare

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

+49 30 243450
Geneststrasse 5
Berlin, 10829

:
ISIN: US29428N2018
: